Solid lipid nanoparticles (SLNs) derived from para-acyl-calix[9]-arene: Preparation and stability

Journal of Microencapsulation

Volumn 27, Issue 7, 2010, Pages 561-571

  Jebors, Saïd ^a   Leydier, Antoine ^b   Wu, Qiongzhi ^b   Bertino Ghera, Bernard ^b   Malbouyre, Marilyne ^b   Coleman, Anthony W ^b  

^a UNIVERSITÉ LYON 1   (France)

^b INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

Author keywords

Amphiphiles; Calix arenes; Encapsulation; Preparation; Solid lipid nanoparticles; Stability

Indexed keywords

4 ACYLCALIX[9]ARENE; ALBUMIN; AMPHOPHILE; CALIXARENE; DISACCHARIDE; MONOSACCHARIDE; ORGANIC SOLVENT; SODIUM CHLORIDE; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ALBUMIN BLOOD LEVEL; ARTICLE; CHEMICAL PARAMETERS; CRYOPROTECTION; DRUG STABILITY; ELECTRON MICROSCOPY; HUMAN; IONIC STRENGTH; LIGHT SCATTERING; NANOENCAPSULATION; PARTICLE SIZE; PROTEIN INTERACTION; SUSPENSION; ULTRASOUND; ULTRAVIOLET RADIATION; VISCOSITY;

ACYLATION; CALIXARENES; CHEMISTRY, PHARMACEUTICAL; CRYOPROTECTIVE AGENTS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; LIPIDS; MICROSCOPY, ELECTRON; NANOCAPSULES; NANOPARTICLES; ORGANIC CHEMICALS; PARTICLE SIZE; SCATTERING, RADIATION; SOLVENTS; SURFACE-ACTIVE AGENTS; SUSPENSIONS; TEMPERATURE; TIME FACTORS; VISCOSITY; WATER;

EID: 77957804302     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2010.493620     Document Type: Article

References (42)

1. Abdelwahed W, Degobert G, Dubes A, Parrot-Lopez H, Fessi H. 2008. Sulfated and non-sulfated amphiphilic-ß-cyclodextrins: impact of their structural properties on the physicochemical properties of nanoparticles. Int J Pharm 351:289-295.
2. Ananchenko GS, Udachin KA, Dubes A, Ripmeester JA, Perrier T, Coleman AW. 2006. Guest exchange in single crystals of van der Waals nanocapsules. Angew Chem Int Ed Engl 45:1585-1588.
3. Ananchenko GS, Udachin KA, Coleman AW, Polovyanenko DN, Bagryanskaya EG, Ripmeester JA. 2008. Crystalline inclusion complex of a calixarene with a nitroxide. Chem Commun 223-225.
4. Bertino Ghera B, Wu Q, Leydier A, Coleman AW. 2008. Para-acyl-calix[9] arenes: synthesis and interfacial assembly. J Incl Phenom Macrocyl Chem 64:367-371.
5. Coleman AW, Jebors S, Cecillon S, Perret P, Garin D, Marti-Battle D, Moulin M. 2008a. Toxicity and biodistribution of para-sulfonatocalix[4]arene in mice. New J Chem 32:780-782.
6. Coleman AW, Jebors S, Shahgaldian P, Ananchenko GS, Ripmeester JA. 2008b. Para-acylcalix[n]arenes: from molecular to macroscopic assemblies. Chem Commun 2291-2303.
7. Combaut G, Chantraine J-M, Teste J, Glombitza K-W. 1978. Phenols bromes des algues rouges: cyclotribromoveratrylene, nouveau derive obtenu au cours de l'extraction de Halopytis pinaströides. Phytochemistry 17:1791-1792.
8. Debuigne F, Jeunieau L, Wiame M, Nagy JB. 2000. Synthesis of organic nanoparticles in different W/O microemulsions. Langmuir 16:7605-7611.
9. Dubes A, Parrot-Lopez H, Abdelwahed W, Degobert G, Fessi H, Shahgaldian P, Coleman AW. 2003. Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur J Pharm Biopharm 55:279-282.
10. Gansey MHBG, De Haan AS, Bos ES, Verboom W, Reinhoudt DN. 1999. Conjugation, immunoreactivity, and immunogenicity of calix[4]arenes; model study to potential calix[4]arene-based Ac3+ chelators. Bioconjug Chem 10:613-623.
11. Gutsche CD. 1989. Calixarenes revisited: monographs in supramolecular chemistry. Cambridge: The Royal Society of Chemistry.
12. Houel E, Lazar A, Da Silva E, Coleman AW, Solovyov A, Cherenok S, Kalchenko V. 2002. Interfacial interactions of cations with amphiphilic dihydroxyphosphonyl-calix-[4]-arene mesosystems. Langmuir 18:1374-1379.
13. Jebors S, Fache F, Balme S, Devoge F, Monachino M, Cecillon S, Coleman AW. 2008. Designer amphiphiles based on para-acyl-calix[8]arenes. Org Biomol Chem 6:319-329.
14. Jeon H-J, Jeong Y-I, Jang M-K, Park Y-H, Nah J-W. 2000. Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. Int J Pharm 207:99-108.
15. Jeong Y-I, Cho C-S, Kim S-H, Ko K-S, Kim S-I, Shim Y-H, Nah J-W. 2001. Preparation of poly(DL-lactide-co-glycolide) nanoparticles without surfactant. J Appl Polym Sci 80:2228-2236.
16. Leray E, Leroylechat F, Parrotlopez H, Duchene D. 1995. Reduction of the haemolytic effect in a biologically recognisable ß-cyclodextrin. Supramolecular Chem 5:149-151.
17. Lian T, Ho RJY. 2001. Trends and developments in liposome drug delivery systems. J Pharm Sci 90:667-680.
18. Lide DR. 2009. CRC handbook of chemistry and physics. 89th ed. Boca Raton, FL: Taylor and Francis.
19. Miyajima K. 1997. Role of saccharides for the freeze-thawing and freeze drying of liposome. Adv Drug Deliv Rev 24:151-159.
20. Moselhy J, Wu XY, Nicholov R, Kodaria K. 2000. In vitro studies of the interaction of poly(NIPAm/MAA) nanoparticles with proteins and cells. J Biomater Sci Polym Ed 11:123-147.
21. Muller RH, Keck CM. 2004. Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 113:151-170.
22. Muller RH, Mader K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm 50:161-177.
23. Muller RH, Runge SA. 1998. Solid lipid nanoparticles (SLN) for controlled drug delivery. Drug Target Deliv 9:219-234.
24. Perrier E, Nicholas T, Rival D, Coleman A. 2001. (Coletica, Fr.). AN 2001:842310.
25. Peters Jr T. 1996. All about albumin. London, UK: Academic Press.
26. Pojarova M, Ananchenko GS, Udachin KA, Daroszewska M, Perret F, Coleman AW, Ripmeester JA. 2006. Solid lipid nanoparticles of p-hexanoyl calix[4]arene as a controlling agent in the photochemistry of a sunscreen blocker. Chem Mater 18:5817-5819.
27. Quintanar-Guerrero D, Allemann E, Fessi H, Doelker E. 1998a. Preparation techniques and mechanisms of formation ofbiodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm 24:1113-1128.
28. Quintanar-Guerrero D, Fessi H, Allemann E, Doelker E. 1996. Influence of stabilizing agents and preparative variables on the formation of poly(D,L-lactic acid) nanoparticles by an emulsification-diffusion technique. Int J Pharm 143:133-141.
29. Quintanar-Guerrero D, Ganem-Quintanar A, Allemann E, Fessi H, Doelker E. 1998b. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared byanemulsion-diffusiontechnique.JMicroencapsul 15:107-119.
30. Rival D, Terry N, Bonnet S, Sohm B, Perrier E, Coleman A. 2006. Nanosized particles based on beta-cyclodextrin esters. SOFW J 132:54-62.
31. Schneider H-J, Yatsimirsky AK, 2000. Principles and methods in supramolecular chemistry. Wiley-VCH: Weinheim.
32. Scholer N, Olbrich C, Tabatt K, Muller RH, Hahn H, Liesenfeld O. 2001. Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages. Int J Pharm 221:57-67.
33. Shahgaldian P, Cesario M, Goreloff P, Coleman AW. 2002. Para-acyl calix[4]arenes: amphiphilic self-assembly from the molecular to the mesoscopic level. Chem Commun 326-327.
34. Shahgaldian P, Coleman AW, Kalchenko VI. 2001. Synthesis and properties of novel amphiphilic calix-[4]-arene derivatives. Tetrahedron Lett 4:577-579.
35. Shahgaldian P, Da Silva E, Coleman AW, Rather B, Zaworotko MJ. 2003. Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters. Int J Pharma 253:23-38.
36. Shidhaye SS, Vaidya R, Sutar S, Patwardhan A, Kadam VJ. 2008. Solid lipid nanoparticles and nanostructured lipid carriers-innovative generations of solid lipid carriers. Curr Drug Deliv 5:324-331.
37. Song CX, Labhasetwar V, Murphy H, Qu X, Humphrey WR, Shebuski RJ, Levy RJ. 1997. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J Control Release 43:197-212.
38. Souto EB, Almeida AJ, Muller RH. 2007. Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: structure, protection and skin effects. J Biomed Nanotechnol 3:317-331.
39. Steed JW, Atwood JL, 2009. Supramolecular chemistry. 2nd ed. Chinchester: John Wiley.
40. Szejtli J. 1998. Introduction and general overview of cyclodextrin chemistry. Chem Rev 98:1743-1753.
41. Zimmermann E, Muller RH. 2001. Electrolyte-and pH-stabilities of aqueous solid lipid nanoparticle (SLNTM) dispersions in artificial gastrointestinal media. Eur J Pharm Biopharm 52:203-210.
42. Zimmermann E, Muller RH, Mader K. 2000. Influence of different parameters on reconstitution of lyophilized SLN. Int J Pharm 196:211-213.